老年人单次经皮双瓣膜置入术的可行性与挑战。

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Seifollah Abdi, Iraj Nazeri, Mohammad Hossein Mandegar, Babak Geraiely, Hamidreza Soleimani, Mehrdad Mahalleh, Sadaf Agahi, Amir Abdi, Farnoosh Larti
{"title":"老年人单次经皮双瓣膜置入术的可行性与挑战。","authors":"Seifollah Abdi, Iraj Nazeri, Mohammad Hossein Mandegar, Babak Geraiely, Hamidreza Soleimani, Mehrdad Mahalleh, Sadaf Agahi, Amir Abdi, Farnoosh Larti","doi":"10.1080/14796678.2025.2508108","DOIUrl":null,"url":null,"abstract":"<p><p>The 2021 ESC/EACTS guidelines recommend percutaneous approaches for failing bioprostheses. These methods are less invasive, resulting in shorter recovery times and fewer complications. Valve-in-valve (ViV) procedures offer a promising solution, although simultaneous transcatheter replacement of two valves (double ViV) still needs to be standard and primarily documented through case reports. This case series presents the initial outcomes of two patients who underwent simultaneous double transcatheter heart valve implantation, exploring the feasibility of this approach in the elderly. As the demand for bioprosthetic valves grows, innovative strategies like double ViV may provide valuable solutions to address valve degeneration and enhance patient outcomes.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-7"},"PeriodicalIF":1.6000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Feasibility and challenges of single-session percutaneous double valve in valve implantation in the elderly.\",\"authors\":\"Seifollah Abdi, Iraj Nazeri, Mohammad Hossein Mandegar, Babak Geraiely, Hamidreza Soleimani, Mehrdad Mahalleh, Sadaf Agahi, Amir Abdi, Farnoosh Larti\",\"doi\":\"10.1080/14796678.2025.2508108\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The 2021 ESC/EACTS guidelines recommend percutaneous approaches for failing bioprostheses. These methods are less invasive, resulting in shorter recovery times and fewer complications. Valve-in-valve (ViV) procedures offer a promising solution, although simultaneous transcatheter replacement of two valves (double ViV) still needs to be standard and primarily documented through case reports. This case series presents the initial outcomes of two patients who underwent simultaneous double transcatheter heart valve implantation, exploring the feasibility of this approach in the elderly. As the demand for bioprosthetic valves grows, innovative strategies like double ViV may provide valuable solutions to address valve degeneration and enhance patient outcomes.</p>\",\"PeriodicalId\":12589,\"journal\":{\"name\":\"Future cardiology\",\"volume\":\" \",\"pages\":\"1-7\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-05-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/14796678.2025.2508108\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2025.2508108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

2021年ESC/EACTS指南推荐经皮入路治疗失败的生物假体。这些方法侵入性小,恢复时间短,并发症少。尽管同时经导管置换两个瓣膜(双ViV)仍然需要成为标准,并主要通过病例报告进行记录,但阀中阀(ViV)手术提供了一个很有前途的解决方案。本病例系列介绍了两例同时行双导管心脏瓣膜置入术的患者的初步结果,探讨了这种方法在老年人中的可行性。随着对生物假体瓣膜需求的增长,像双ViV这样的创新策略可能为解决瓣膜变性和提高患者预后提供有价值的解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Feasibility and challenges of single-session percutaneous double valve in valve implantation in the elderly.

The 2021 ESC/EACTS guidelines recommend percutaneous approaches for failing bioprostheses. These methods are less invasive, resulting in shorter recovery times and fewer complications. Valve-in-valve (ViV) procedures offer a promising solution, although simultaneous transcatheter replacement of two valves (double ViV) still needs to be standard and primarily documented through case reports. This case series presents the initial outcomes of two patients who underwent simultaneous double transcatheter heart valve implantation, exploring the feasibility of this approach in the elderly. As the demand for bioprosthetic valves grows, innovative strategies like double ViV may provide valuable solutions to address valve degeneration and enhance patient outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Future cardiology
Future cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.80
自引率
5.90%
发文量
87
期刊介绍: Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信